Published in Saudi J Gastroenterol on February 02, 2016
Writing, erasing and reading histone lysine methylations. Exp Mol Med (2017) 0.75
Global cancer statistics, 2002. CA Cancer J Clin (2005) 119.22
Epigenetics in cancer. N Engl J Med (2008) 17.36
HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target. Ann Oncol (2008) 4.63
Epigenetic gene silencing in cancer: the DNA hypermethylome. Hum Mol Genet (2007) 3.12
Molecular-pathological prognostic factors of gastric cancer: a review. Gastric Cancer (2005) 2.12
UHRF1 binds G9a and participates in p21 transcriptional regulation in mammalian cells. Nucleic Acids Res (2008) 1.80
Clinicopathologic characteristics and prognostic factors in 10 783 patients with gastric cancer. Gastric Cancer (1998) 1.79
Proteomic analysis of chronic pancreatitis and pancreatic adenocarcinoma. Gastroenterology (2005) 1.61
The UHRF family: oncogenes that are drugable targets for cancer therapy in the near future? Pharmacol Ther (2007) 1.59
p53 and VEGF expression are independent predictors of tumour recurrence and survival following curative resection of gastric cancer. Br J Cancer (2004) 1.56
Prognostic significance of p53 overexpression in gastric and colorectal carcinoma. Br J Cancer (1992) 1.47
Gastric cancer with p53 overexpression has high potential for metastasising to lymph nodes. Br J Cancer (1993) 1.22
UHRF1 is a novel molecular marker for diagnosis and the prognosis of bladder cancer. Br J Cancer (2009) 1.18
UHRF1 is a novel diagnostic marker of lung cancer. Br J Cancer (2010) 1.18
The relationship of p53 expression to the prognosis of 418 patients with gastric carcinoma. Cancer (1995) 1.17
The SRA protein UHRF1 promotes epigenetic crosstalks and is involved in prostate cancer progression. Oncogene (2012) 1.16
Drug discovery targeting epigenetic codes: the great potential of UHRF1, which links DNA methylation and histone modifications, as a drug target in cancers and toxoplasmosis. Biochem Pharmacol (2009) 1.11
Cell cycle and/or proliferation markers: what is the best method to discriminate cervical high-grade lesions? Hum Pathol (2005) 1.11
Regulation of UHRF1 by miR-146a/b modulates gastric cancer invasion and metastasis. FASEB J (2013) 1.06
Epigenetic mechanisms in gastric cancer. Epigenomics (2012) 1.05
DNA and histone methylation in gastric carcinogenesis. World J Gastroenterol (2013) 1.03
Prognostic value of p53 protein expression for patients with gastric cancer--a multivariate analysis. Br J Cancer (1999) 0.99
Clinicopathological and prognostic significance of Ki-67, caspase-3 and p53 expression in gastric carcinomas. Oncol Lett (2013) 0.97
Expression of p53 protein in gastric carcinomas. Association with histologic type and prognosis. Am J Surg Pathol (1994) 0.92
Prognostic value of p53 protein and MK-1 (a tumor-associated antigen) expression in gastric carcinoma. Gastric Cancer (2007) 0.86
Immunohistochemical study of p53 in gastric carcinoma. Am J Clin Pathol (1994) 0.85
Diagnostic and prognostic value of plasma and tissue ubiquitin-like, containing PHD and RING finger domains 1 in breast cancer patients. Cancer Sci (2012) 0.83
Cancer prevention: a global perspective. J Clin Oncol (2005) 0.82
Clinicopathological significance and survival influence of p53 protein expression in gastric carcinoma. Histopathology (2004) 0.82
Rituximab-related viral infections in lymphoma patients. Leuk Lymphoma (2007) 2.55
Cutaneous melanoma in Turkey: analysis of 1157 patients in the Melanoma Turkish Study. J BUON (2015) 1.97
Bevacizumab, bleeding, thrombosis, and warfarin. J Clin Oncol (2003) 1.41
Hypocalcemic effect of zoledronic acid or other bisphosphonates may contribute to their antiangiogenic properties. Med Hypotheses (2004) 1.39
Could the neutrophil to lymphocyte ratio be a poor prognostic factor for non small cell lung cancers? Asian Pac J Cancer Prev (2014) 1.09
Dose-dense effect: other contributors. Lancet Oncol (2013) 1.07
Aromatase inhibitors and safety: clinical or statistical significance? J Clin Oncol (2013) 1.05
First-line crizotinib in ALK-positive lung cancer. N Engl J Med (2015) 1.01
Prognostic factors for teenage and adult patients with high-grade osteosarcoma: an analysis of 240 patients. Med Oncol (2013) 0.99
Metastatic granular cell tumor: a case report and review of the literature. Acta Oncol (2006) 0.97
Value of Doppler sonography in assessing the progression of chronic viral hepatitis and in the diagnosis and grading of cirrhosis. J Ultrasound Med (2005) 0.92
Characteristics of breast cancer patients with central nervous system metastases: a single-center experience. J Natl Med Assoc (2008) 0.90
Orbital metastasis from adenocarcinoma of the colon. South Med J (2005) 0.88
Results of adjuvant FOLFOX regimens in stage III colorectal cancer patients: retrospective analysis of 667 patients. Oncology (2013) 0.87
Clinical characteristics, treatment and survival outcomes in malignant mesothelioma: eighteen years' experience in Turkey. Asian Pac J Cancer Prev (2012) 0.87
Medication errors in chemotherapy preparation and administration: a survey conducted among oncology nurses in Turkey. Asian Pac J Cancer Prev (2015) 0.85
Low ERCC1 expression is associated with prolonged survival in patients with bladder cancer receiving platinum-based neoadjuvant chemotherapy. Urol Oncol (2012) 0.83
Liver dysfunction after chemotherapy in lymphoma patients infected with hepatitis C. Eur J Haematol (2008) 0.82
Endobronchial metastasis of thyroid follicular carcinoma. J Natl Med Assoc (2006) 0.81
Survival analysis and prognostic factors for neuroendocrine tumors in Turkey. Asian Pac J Cancer Prev (2014) 0.81
Multicenter epidemiologic study on hepatocellular carcinoma in Turkey. Asian Pac J Cancer Prev (2014) 0.80
A new perspective to determine the severity of cases with Crimean-Congo hemorrhagic fever. J Vector Borne Dis (2012) 0.80
Paclitaxel, not bevacizumab, was primarily responsible for the favorable effects seen in the RIBBON-2 trial. J Clin Oncol (2011) 0.79
Lung cancer in women: a single institution experience with 50 patients. Asian Pac J Cancer Prev (2014) 0.78
Prognosis of colorectal cancer with peritoneal carcinomatosis: is a new staging necessary? J Clin Oncol (2012) 0.78
Determination of circulating tumor cells for detection of colorectal cancer progression or recurrence. Hepatogastroenterology (2011) 0.78
Evaluation of quality of life in Turkish patients with head and neck cancer. Asian Pac J Cancer Prev (2013) 0.78
Recurrence risk and prognostic parameters in stage I rectal cancers. Asian Pac J Cancer Prev (2014) 0.78
End-of-study results of Turkish gastric cancer patients from the global REGATE study. J BUON (2014) 0.78
Erectile dysfunction in successfully treated lymphoma patients. Support Care Cancer (2007) 0.77
Predictive role of neutrophil gelatinase-associated lipocalin in early diagnosis of platin-induced renal injury. Asian Pac J Cancer Prev (2015) 0.77
Lack of relationships between FGF19 staining pattern, lymph node metastasis and locally invasive characteristics of the tumor in colorectal cancers. Asian Pac J Cancer Prev (2013) 0.77
Gefitinib efficacy in relapsed small-cell lung cancer. Lung Cancer (2006) 0.77
Lack of association between the MTHFRC677T polymorphism and lung cancer in a Turkish population. Asian Pac J Cancer Prev (2014) 0.77
A novel immunosuppressive agent, sirolimus, in the treatment of Kaposi's sarcoma in a renal transplant recipient. Ren Fail (2007) 0.77
Predictors of outcome in patients with advanced nonseminomatous germ cell testicular tumors. Asian Pac J Cancer Prev (2014) 0.77
Comparison of Clinicopathologic Parameters and Survivals Between Epstein-Barr Virus-positive and Her2-positive Gastric Cancers. Appl Immunohistochem Mol Morphol (2016) 0.77
Prognostic factors in gastrointestinal stromal tumors: multicenter experience of 333 cases from Turkey. Hepatogastroenterology (2012) 0.76
Investigation of antitumor effects of sorafenib and lapatinib alone and in combination on MCF-7 breast cancer cells. Asian Pac J Cancer Prev (2014) 0.76
Improved anti-emetic efficacy of 5-HT3 receptor antagonists in cancer patients with genetic polymorphisms of ABCB1 (MDR1) drug transporter. Basic Clin Pharmacol Toxicol (2014) 0.75
Insulin therapy and cancer-specific mortality in patients with colorectal cancer and diabetes. J Clin Oncol (2012) 0.75
Alpha-fetoprotein response after locoregional therapy for hepatocellular carcinoma. J Clin Oncol (2010) 0.75
P95 HER2 fragments and breast cancer outcome. Expert Rev Anticancer Ther (2014) 0.75
Risk of venous thromboembolism with bevacizumab in cancer patients. JAMA (2009) 0.75
Letter to the editor. Women with HER2-positive metastatic breast cancer have significantly longer survival after diagnosis of brain metastasis(BM) than those with HER2-negative disease. Am J Clin Oncol (2009) 0.75
Multivariate analysis of factors predictive of brain metastases in localised non-small call lung carcinoma. Lung Cancer (2005) 0.75
Acrocyanosis as a presenting symptom of Hodgkin lymphoma. Am J Hematol (2006) 0.75
The effect on prognosis of postoperative CA 19-9 level in patients with pancreatic cancer. Am J Clin Oncol (2010) 0.75
Morphologic and Metabolic Comparison of Treatment Responsiveness with 18Fludeoxyglucose-Positron Emission Tomography/Computed Tomography According to Lung Cancer Type. Mol Imaging Radionucl Ther (2016) 0.75
Ca 19-9 measurement as a screening: higher cost, lower survival. J Gastroenterol Hepatol (2004) 0.75
The Diagnostic Value of the Correlation between Serum Anti-p53 Antibody and Positron Emission Tomography Parameters in Lung Cancer. Mol Imaging Radionucl Ther (2016) 0.75
Fludarabine phosphate may be useful in the treatment of graft-versus-host disease. Med Hypotheses (2005) 0.75
Potential impact of atelectasis and primary tumor glycolysis on F-18 FDG PET/CT on survival in lung cancer patients. Asian Pac J Cancer Prev (2014) 0.75
Therapeutic proteins in tumors and targeted therapeutic agents for cancer patients. Protein Pept Lett (2013) 0.75
Oxaliplatin and ototoxicity: is it really safe for hearing? Turk J Med Sci (2014) 0.75
Assessment of tumor characteristics and factors affecting survival in patients with primary metastatic breast carcinoma: a Multicenter Study of the Anatolian Society of Medical Oncology. Med Oncol (2014) 0.75
Chemotherapy-induced spontaneous orgasms in a patient with breast cancer. Ann Pharmacother (2012) 0.75
Treatment of comorbidities besides the treatment of primary tumor may further increase effective management of cancer. Med Hypotheses (2006) 0.75
Tendency of cancer patients and their relatives to use internet for health-related searches: Turkish Oncology Group (TOG) Study. J BUON (2016) 0.75
Concentration modulated skin marker for radiotherapy treatment planning process. Phys Med (2012) 0.75
Evaluation of complementary and alternative medicine trials registered in clinicaltrials.gov database. J BUON (2017) 0.75
Efficacy and safety of eribulin monotherapy in patients with heavily pretreated metastatic breast cancer. J BUON (2016) 0.75
Smoking habits of relatives of patients with cancer: cancer diagnosis in the family is an important teachable moment for smoking cessation. Asian Pac J Cancer Prev (2013) 0.75
Serum levels of alpha-tocopherol, vitamin C, beta-carotene, and retinol in malignant pleural mesothelioma. Asian Pac J Cancer Prev (2012) 0.75
Significant Association Between Polymorphisms of Wnt Antagonist Genes and Lung Cancer. J Investig Med (2015) 0.75
Assessing anxiety levels and empathic tendency in blood and platelet donors. Transfus Apher Sci (2013) 0.75
Procarbazine, lomustine, vincristine combination may be effective in adult medulloblastoma patients with systemic metastases. J Neurooncol (2005) 0.75
Complete remission after bevacizumab plus temozolomide in a patient with recurrent glioblastoma multiforme. Acta Oncol (2011) 0.75
Malignant eccrine poroma presenting with pulmonary and liver metastases. Int J Dermatol (2006) 0.75
Calcified lymph nodes in Hodgkin's lymphoma. Leuk Lymphoma (2006) 0.75
Extensive exfoliative dermatitis induced by chlorambucil. Am J Hematol (2006) 0.75
Nasopharynx carcinoma complicated with pneumocephalus. J Neurooncol (2005) 0.75
Successful salvage therapy of resistant gestational trophoblastic disease with ifosfamide and paclitaxel. Gynecol Oncol (2005) 0.75
XELOX plus bevacizumab vs. FOLFIRI plus bevacizumab treatment for first-line chemotherapy in metastatic colon cancer: a retrospective study of the Anatolian Society of Medical Oncology. Asian Pac J Cancer Prev (2014) 0.75
Lithium-associated hypothyroidism and thyroid papillary carcinoma: a case report. South Med J (2006) 0.75
Attitudes of cancer patients after diagnosis: How cancer affects social life? A Turkish Oncology Group study. J BUON (2017) 0.75